文献速递皮肤肿瘤

原发性皮肤肢端CD8+ T细胞淋巴瘤及其他真皮CD8+皮肤淋巴增殖性疾病的临床、组织病理学和预后特征:EORTC皮肤淋巴瘤组研讨会结果

Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop.
PubMed 文献 · Br J Dermatol · 2022-01-01

该研究为EORTC皮肤淋巴瘤组对46例真皮CD8+淋巴增殖性疾病的回顾性分析,将其分为三组:原发性皮肤肢端CD8+ T细胞淋巴瘤(n=31)、原发性皮肤CD8+外周T细胞淋巴瘤非特指型(n=11)及与免疫缺陷相关的皮肤CD8+淋巴增殖性疾病(n=4)。结论认为综合临床、组织病理和表型特征可区分不同疾病实体,正确诊断对避免过度治疗和识别免疫缺陷或预后不良病例至关重要。

要点

  • 真皮CD8+淋巴增殖性疾病可分为三组:肢端CD8+ T细胞淋巴瘤、原发性皮肤CD8+外周T细胞淋巴瘤非特指型、免疫缺陷相关CD8+淋巴增殖性疾病。
  • 肢端CD8+ T细胞淋巴瘤多表现为肢端孤立结节,小至中等CD8+淋巴细胞单调浸润,CD68呈点状模式,增殖率低,预后极好。
  • 原发性皮肤CD8+外周T细胞淋巴瘤非特指型常表现为快速进展的肿瘤,中至多形性CD8+肿瘤细胞表达细胞毒标记,增殖活性高。

核心结论

  • 综合不同的临床、组织病理学和表型特征可将真皮CD8+浸润分为不同疾病实体;原发性皮肤肢端CD8+淋巴瘤在当前淋巴瘤分类中为暂定类别,是独立且可重复的实体;正确诊断对避免对惰性CD8+淋巴增殖性疾病进行不必要的积极治疗、识别潜在免疫缺陷或预后不良病例至关重要。

研究设计与样本

  • EORTC皮肤淋巴瘤组国际多中心回顾性分析,共纳入46例患者及活检标本。

主要发现

  • 真皮CD8+淋巴增殖性疾病(n=46)分为三组:肢端CD8+ T细胞淋巴瘤(n=31)、原发性皮肤CD8+外周T细胞淋巴瘤非特指型(n=11)、皮肤CD8+淋巴增殖性疾病(n=4)。
  • 肢端CD8+ T细胞淋巴瘤多表现为肢端孤立结节,小至中等CD8+淋巴细胞单调真皮浸润,CD68呈特征性点状模式,增殖率低,预后极好。
  • 原发性皮肤CD8+外周T细胞淋巴瘤非特指型表现为一个或多个快速演变的肿瘤,多为中等大小多形性CD8+肿瘤细胞,表达多种细胞毒标记,增殖活性高。
  • 皮肤CD8+淋巴增殖性疾病组中2例与先天性免疫缺陷综合征相关,表现为肢体持续性局限性或播散性紫罗兰色至褐色斑块,组织细胞丰富浸润,主要为小CD8+淋巴细胞伴轻微异型性,病程迁延;另2例为获得性免疫抑制患者的丘疹性CD8+皮疹。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The differential diagnosis of atypical dermal nonepidermotropic CD8+ lymphocytic infiltrates includes a heterogeneous spectrum of lymphoproliferations with overlapping histological and phenotypic features, but divergent clinical manifestations and prognoses. As these neoplasms are rare, more data on their clinicopathological presentation and course are needed. OBJECTIVES: To assess the clinical, histological and immunophenotypic features; outcomes of; and differences between dermal CD8+ lymphoproliferations. METHODS: Retrospective analysis of a series of 46 patients and biopsies by the international EORTC Cutaneous Lymphoma Group. RESULTS: The dermal CD8+ lymphoproliferations (n = 46) could be assigned to one of three groups: (i) cutaneous acral CD8+ T-cell lymphoma (n = 31), characterized mostly by a solitary nodule arising at acral sites, a monotonous dermal infiltrate of small-to-medium-sized CD8+ lymphocytes with a characteristic dot-like pattern of CD68, a low proliferation rate and an excellent prognosis; (ii) primary cutaneous CD8+ peripheral T-cell lymphoma, unspecified/NOS (n = 11), presenting with one or multiple rapidly evolving tumours, mostly medium-sized pleomorphic CD8+ tumour cells with expression of several cytotoxic markers, and high proliferative activity; and (iii) cutaneous CD8+ lymphoproliferations (n = 4), associated with congenital immunodeficiency syndromes in two patients with persisting localized or disseminated violaceous to brownish plaques on the extremities, a histiocyte-rich infiltrate of mostly small CD8+ lymphocytes with subtle atypia and a protracted course; and papular CD8+ eruptions in two patients with acquired immunosuppression. CONCLUSIONS: A constellation of distinct clinical, histopathological and phenotypic features allows discrimination and assignment of dermal CD8+ infiltrates into distinct disease entities. Primary cutaneous acral CD8+ lymphoma, assigned a provisional category in current lymphoma classifications, is a distinct and reproducible entity. A correct diagnosis is essential to avoid unnecessarily aggressive treatment for indolent CD8+ lymphoproliferations and to identify cases with underlying immuno-deficiency or potential for dismal outcome.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Kempf W, Petrella T, Willemze R, et al. Clinical, histopathological and prognostic features of primary cutaneous acral CD8+ T-cell lymphoma and other dermal CD8+ cutaneous lymphoproliferations: results of an EORTC Cutaneous Lymphoma Group workshop. Br J Dermatol. 2022. PMID: 34988968. doi:10.1111/bjd.20973

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。